TickrTrends CDNA fair value analysis

CareDx Inc (CDNA) Stock Up 13.0% but GF Value Says Overvalued -- GF Score: 66/100

gurufocus.com · 2026-09-25

On September 24, 2026, CareDx Inc (CDNA) shares rose 13.0% to a current price of $61.37, marking a notable increase in the stock's performance. Over the past ye

TickrTrends take: CareDx stock has risen 13 percent, yet TickrTrends' valuation assessment aligns with external analysis indicating the stock trades above its intrinsic value. The Healthcare sector stock carries a GF Score of 66 out of 100, suggesting mixed fundamental quality that investors focused on valuation should weigh against the recent price appreciation. A reader concerned with value metrics should monitor whether the stock can justify its current premium or if it faces pressure to revert toward fair value levels.

Read the full story at gurufocus.com →

Is CDNA undervalued? See TickrTrends' fair value analysis →